182 related articles for article (PubMed ID: 10553420)
1. [Combined chemotherapy with low-dose cisplatin, tegafur and uracil for head and neck squamous cell carcinomas].
Nishino H; Abe K; Ishikawa K; Kanazawa T; Tanaka H; Miyata M; Kitamura K; Morita M
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1617-21. PubMed ID: 10553420
[TBL] [Abstract][Full Text] [Related]
2. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
[TBL] [Abstract][Full Text] [Related]
3. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
[TBL] [Abstract][Full Text] [Related]
4. [Results of combination therapy of UFT-E with low-dose CDDP for patients with advanced recurrent breast cancer].
Ito T; Yamada M; Tanemura H; Oshita H; Asano M; Saji S
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1575-80. PubMed ID: 9725051
[TBL] [Abstract][Full Text] [Related]
5. [Low-dose cisplatin added to continuous infusion of 5-fluorouracil or oral administration of UFT for inoperable advanced or recurrent colorectal cancer].
Asano M; Mori T; Takahashi K; Yasuno M
Gan To Kagaku Ryoho; 1997 Jan; 24(1):55-60. PubMed ID: 9020946
[TBL] [Abstract][Full Text] [Related]
6. [The effect of induction chemotherapy with CBDCA, 5-FU and UFT in head and neck cancer].
Homma A; Iizuka K; Nakamaru Y; Yonekawa H
Gan To Kagaku Ryoho; 1994 Apr; 21(5):627-31. PubMed ID: 8154888
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.
Hussain M; Gadgeel S; Kucuk O; Du W; Salwen W; Ensley J
Cancer; 1999 Dec; 86(11):2364-9. PubMed ID: 10590379
[TBL] [Abstract][Full Text] [Related]
9. [Outpatient chemotherapy with oral UFT (tegafur and uracil) and cisplatin against metastatic non-small cell lung carcinoma--an effective case].
Uehara T; Yano T; Kanematsu T; Terazaki Y; Kuninaka S; Fukuyama Y; Yokoyama H; Asoh H; Ichinose Y
Gan To Kagaku Ryoho; 1999 Jan; 26(1):137-9. PubMed ID: 9987510
[TBL] [Abstract][Full Text] [Related]
10. [Low-dose CDDP and 5-FU for head and neck cancer patients].
Fujii M; Kanke M; Tomita T
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1542-7. PubMed ID: 10553410
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
[TBL] [Abstract][Full Text] [Related]
12. [Concurrent chemoradiation using daily low-dose CDDP and UFT-E for postoperative recurrent esophageal cancers].
Akagi Y; Hashimoto Y; Takiyama W; Mukaida H; Murakami Y; Ito K
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1993-7. PubMed ID: 15570927
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
Wang HM; Wang CS; Chen JS; Chen IH; Liao CT; Chang TC
Cancer; 2002 Jun; 94(11):2989-95. PubMed ID: 12115388
[TBL] [Abstract][Full Text] [Related]
14. [Combined chemotherapy with low-dose cisplatin, tegafur and uracil in a case with neck recurrence of laryngeal cancer].
Nishino H; Tanaka H; Ishikawa K; Kanazawa T; Miyata M; Kitamura K
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1973-5. PubMed ID: 9797823
[TBL] [Abstract][Full Text] [Related]
15. [Neo-adjuvant chemotherapy with UFT and adriamycin in head and neck cancer].
Toda K; Kishimoto M; Imura S; Ogasawara H; Hyo N; Kumoi T
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2280-5. PubMed ID: 3111382
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck.
Hitt R; Jimeno A; Millán JM; Castellano D; Cortés-Funes H
Cancer; 2004 Aug; 101(4):768-75. PubMed ID: 15305408
[TBL] [Abstract][Full Text] [Related]
17. [Combination chemotherapy with continuous infusion of low-dose cisplatin and UFT for advanced non-small cell lung cancer].
Seike M; Andoh M; Hasegawa K; Sakonji M; Tsuboi E
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1539-42. PubMed ID: 9725046
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
Adamo V; Ferraro G; Pergolizzi S; Sergi C; Laudani A; Settineri N; Alafaci E; Scimone A; Spano F; Spitaleri G
Oral Oncol; 2004 May; 40(5):525-31. PubMed ID: 15006626
[TBL] [Abstract][Full Text] [Related]
19. [Multi-institutional cooperative study on combination chemotherapy with THP, CDDP and 5-FU for squamous cell carcinoma of the head and neck].
Urade M; Yanagisawa T; Kishimoto H; Yoshioka W; Teranobu O; Shigeta Y; Komori T; Shimada K; Ohnishi M; Tanaka Y; Kamiya Y; Akazawa N; Oko T; Takahashi N; Adachi R; Tanigaki S; Hirata Y; Yakushiji N; Kitamura R; Hashikawa N;
Gan To Kagaku Ryoho; 2001 Jun; 28(6):789-95. PubMed ID: 11432346
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
Rivera F; Vega-Villegas ME; López-Brea M; Isla D; Mayorga M; Galdós P; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Mayordomo J; Rama J; Saiz-Bustillo R; Sanz-Ortiz J
Cancer Chemother Pharmacol; 2008 Jul; 62(2):253-61. PubMed ID: 17901953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
